Elphogene

Prague, CZ · 1 known investors

Elphogene develops oncoMonitor, a liquid biopsy molecular test that detects circulating tumor DNA (ctDNA) from patients' blood for non-invasive monitoring of cancer progression and treatment, primarily for colorectal cancer patients. The company is a biotechnology spin-off from the Genomac Research Institute.